IRD
Opus Genetics, Inc.
5.00$
-1.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -85.8% | +1.2% | -35.0% | +247.8% | +11.2% | +1.6% | -34.1% | +6.8% | +25.5% | -44.2% | -65.0% | – | |
| – | +469,700.0% | – | – | – | – | -99.8% | +46,223.1% | -99.8% | +0.0% | +0.0% | – | – | |
| – | -125.2% | – | -35.0% | +247.8% | -189.9% | – | -171.9% | – | +25.5% | -44.5% | -64.8% | – | |
| – | +9.9% | +23.6% | +28.2% | +47.6% | -21.7% | +13.1% | -24.3% | +6.4% | +62.7% | +1.4% | +6.0% | – | |
| – | +59.6% | +42.4% | -28.2% | -13.7% | +152.1% | -13.0% | -9.1% | -13.6% | -1.8% | +21.3% | +1.6% | – | |
| – | -56.4% | +288.9% | +0.2% | +25.8% | +190.9% | -58.6% | -59.7% | +97.5% | +34.5% | +7.8% | +4.4% | – | |
| – | -185.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | -97.4% | +94.3% | +1,955.9% | -53.4% | -18.4% | – | |
| – | -186.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -114.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -186.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -169.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.